跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 760 条关于
“Neuroblastoma”
全部
760
临床试验
649
药物
25
机构
0
资讯
86
去年
Australia Approves IFINWIL (Eflornithine) for High-Risk Neuroblastoma Treatment
去年
St. Jude Researchers Develop Novel Combination Therapy to Overcome Neuroblastoma Treatment Resistance
3个月前
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma
上个月
Risk-Adapted Frameworks Reshape Pediatric Neuroblastoma Care, New Review Shows
9个月前
Australian Researchers Identify Romidepsin as Breakthrough Treatment for Relapsed Neuroblastoma
去年
CHOP Researchers Propose ALK Inhibitors as New Standard for Hereditary Neuroblastoma
去年
Naxitamab Shows Promising Results in Treating Relapsed/Refractory High-Risk Neuroblastoma
2年前
Eflornithine Approved for High-Risk Neuroblastoma: EMA Approval Still Pending
2年前
Eflornithine (DFMO) Shows Promise in Neuroblastoma Treatment, Receives FDA Approval
5个月前
FDA Grants Fast Track Designation to Daretabart for High-Risk Neuroblastoma Treatment
第 1 页,共 9 页
上一页
下一页